How Can We Assess the Safety of Bioidentical Compounds?
Assessing the safety of bioidentical compounds involves a combination of clinical research, post-market surveillance, and pharmacovigilance. Toxicologists use various methods to evaluate the toxicokinetics and toxicodynamics of these substances, studying how they are absorbed, distributed, metabolized, and excreted by the body. This research helps identify potential toxic effects and establish safe dosage ranges. Additionally, patient monitoring during therapy is essential to detect adverse effects early and adjust treatment accordingly.
